Yoshiki Hirooka

41PUBLICATIONS
82CO-AUTHORS
Food properties (incl. characteristics and health benefits)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 13, 2026
1-Kestose as a Candidate Precision Bioactive Component: From GH32-Dependent Gut Microbiota Regulation to Human Health Enhancement.

|Jul 28, 2026
Clinical Utility and Genomic Landscape of Comprehensive Genomic Profiling in Biliary Tract Tumors: A Single-Center Real-World Study.

|May 27, 2026
Agaro-Oligosaccharide Supplementation Alters the Gut Microbiota, Revealing Potential Agaro-Oligosaccharide-Utilizing Taxa in Healthy Japanese Adults.

|Jan 28, 2026
The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma.

Mizuki Ariga, Teiji Kuzuya, Hisanori Muto

|Dec 30, 2025
Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy.

Teiji Kuzuya, Hisanori Muto, Yoshihiko Tachi

|Dec 11, 2025
Host Dietary Nutrients Shape GH32-Mediated Microbial Responses to Prebiotic Fructans: A Randomized Trial.

Hideaki Takahashi, Tadashi Fujii, Chikako Yamada

Pageof 7

Frequent Collaborators

11 joint publications

Kohei Funasaka

10 joint publications

Teiji Kuzuya

10 joint publications

Kazunori Nakaoka

7 joint publications

Senju Hashimoto